格列齐特对糖尿病大鼠心肌的保护作用及其机制*

doi:10.12047/j.cjap.5999.2020.086

摘要/Abstract

摘要： 目的: 观察格列齐特对糖尿病大鼠心肌保护作用及其可能的机制。方法: 将60只健康SD大鼠随机分为正常组(NC,n=10),造模组(n=50)给予高糖高脂饲料4周后,腹腔注射STZ(45 mg/kg)建立糖尿病大鼠模型,随机抽取以FBG≥16.7 mmol/L作为糖尿病模型建立成功。将造模成功的38只糖尿病大鼠随机分为模型组(MC,n=9)、格列齐特组(Glic,80 mg/kg,n=10)、格列本脲组(Glib,2.5 mg/kg,n=10)、法舒地尔组(Fas,10 mg/kg,n=9);NC组和MC组灌胃等容积蒸馏水,Glic组和Glib组灌胃给药,Fas组采用腹腔注射。各组大鼠每天给药一次,每周记录体质量及空腹血糖(FBG),持续8周。实验结束时取血并测定心脏质量,计算心脏质量指数(HWI);测定各组糖化血红蛋白(HbA1c)、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL-C)、低密度脂蛋白(LDL-C)含量以及血清丙二醛(MDA)水平和超氧化物歧化酶(SOD)活性;通过HE和Masson染色,观察心肌病理变化和组织胶原纤维水平;TUNEL染色观察并计算心肌细胞凋亡率;Western blot法检测心肌组织中RhoA、ROCK1、eNOS、Bcl-2和Bax蛋白表达。结果: 与NC组比较,MC组FBG、HWI、HbA1c、TC、TG、LDL-C、MDA水平,心肌组织胶原沉积和心肌细胞凋亡率以及心肌组织中RhoA、ROCK1、Bax蛋白明显升高,SOD活性及HDL-C、eNOS、Bcl-2和体重显著降低(P＜0.01);与MC组相比,Glic组FBG、HWI、HbA1c、TC、TG、LDL-C和MDA等指标明显下降,心肌组织胶原沉积及心肌细胞凋亡减轻,心肌组织RhoA、ROCK1、Bax蛋白表达下调(P＜0.01或P＜0.05),大鼠体重和血清中SOD活性,HDL-C升高,eNOS、Bcl-2蛋白水平升高(P＜0.01或P＜0.05)。与Glic组相比,Glib组与Fas组体重、血脂、FBG、HWI、MDA以及心肌纤维化和心肌细胞凋亡水平升高,SOD和Bcl-2降低,Glib组心肌组织RhoA、ROCK1、Bax蛋白表达上调(P＜0.01或P＜0.05)。结论: 格列齐特可改善糖尿病大鼠心肌损伤并减轻心肌细胞凋亡水平,其机制可能与降低血糖,改善氧化应激状态,调控RhoA/ROCK1/eNOS信号通路有关。

关键词: 大鼠, 糖尿病心肌病, 格列齐特, 格列本脲, 氧化应激, 凋亡

Abstract: Objective: To investigate the protective effects of gliclazide on myocardium of diabetic rats and its possible mechanisms. Methods: Sixty healthy SD rats were randomly divided into two groups: normal group (NC, n=10) and model group (n=50). Rats in model group were fed with high glucose and high fat diet for 4 weeks and then intraperitoneally injected with STZ (45 mg/kg) to establish a diabetic model and randomly selected FBG ≥ 16.7 mmol / L as a successful diabetes model. Thirty-eight diabetic rats were randomly divided into model group (MC, n=9), gliclazide group (Glic, 80 mg/kg, n=10), glibenclamide group (Glib, 2.5 mg/kg, n=10) and fasudil group (Fas, 10 mg/kg, n=9). NC group and MC group were given equal volume distilled water by gavage, Glic group and Glib group were treated with gliclazide or glibenclamide by gavage, and the Fas group was treated with fasudil by intraperitoneal injection. Rats in each group were given once a day and recorded body mass and fasting blood glucose (FBG) weekly for 8 weeks. At the end of the experiment, the heart weight was measured, and the heart weight index (HWI) was calculated; the contents of glycosylated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL-C), low density lipoprotein (LDL-C), the level of serum malondialdehyde MDA) and the activity of superoxide dismutase (SOD) were measured; the pathological changes of myocardial tissue were observed by HE and Masson staining. The expressions of RhoA, ROCK1, eNOS, Bcl-2 and Bax protein were detected by Western blot. Results: Compared with NC group, in MC group, the levels of FBG, HWI, HbA1c, TC, TG, LDL-C, MDA, myocardial collagen deposition and cardiomyocyte apoptosis rate and RhoA, ROCK1, Bax protein in myocardial tissue were increased significantly, while the SOD activity, the levels of HDL-C, eNOS, Bcl-2 and body weight were decreased significantly (P＜0.01). Compared with MC group, Glic treatment decreased the levels of FBG, HWI, HbA1c, LDL-C, TG, TC and MDA, increased the levels of SOD activity and HDL-C (P＜0.01 or P＜0.05); decreased myocardial collagen deposition, inhibited cardiomyocyte apoptosis (P ＜ 0.01); decreased the expression levels of RhoA, ROCK1 and Bax protein; increased the levels of eNOS and Bcl-2 protein (P＜0.01 or P＜0.05). Compared with Glic group, in Glib group, the levels of blood lipids, BM, FBG, HWI, MDA, myocardial fibrosis and cardiomyocyte apoptosis rate were increased, the levels of SOD and Bcl-2 were decreased, and the expressions of RhoA, ROCK1 and Bax in myocardial tissue were upregulated (P＜0.01 or P＜0.05). Conclusion: Gliclazide significantly alleviates myocardial injury and reduces myocardial apoptosis in diabetic rats, and its mechanism may be related to lowering blood glucose, improving oxidative stress and regulating RhoA / ROCK1 / eNOS signaling pathway.

Key words: rats, diabetic cardiomyopathy, Gliclazide, Glibenclamide, oxidative stress, apoptosis

中图分类号:

R969.3

潘文强, 王书凡, 丁伯平, 黄帧桧. 格列齐特对糖尿病大鼠心肌的保护作用及其机制^*[J]. 中国应用生理学杂志, 2020, 36(5): 402-407.

PAN Wen-qiang, WANG Shu-fan, DING Bo-ping, HUANG Zhen-gui. Protective effects of gliclazide on myocardium of diabetic rats and its mechanism[J]. CJAP, 2020, 36(5): 402-407.

参考文献

[1] Avogaro A, Fadini GP. Insulin treatment in patients with diabetes and heart failure: defendant on the stand[J]. Eur J Heart Fail, 2018, 20(5): 896-897.
[2] Othman AI, El-Sawi MR, El-Missiry MA, et al. Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats[J]. Biomed Pharmacother, 2017, 94(3): 362-373.
[3] Althunibat OY, Al Hroob AM, Abukhalil MH, et al. Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic cardiomyopathy[J]. Life Sci, 2019, 221(15): 83-92.
[4] Chia YMF, Teng TK, Chandramouli C, et al. Clinical correlates and pharmacological management of Asian patients with concomitant diabetes mellitus and heart failure[J]. Heart Fail Rev, 2018, 23(3): 461-468.
[5] Parim B, Sathibabu Uddandrao VV, Saravanan G. Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy [J]. Heart Fail Rev, 2019, 24(2): 279-299.
[6] Zhang YW, Wang X, Ren X, et al. Involvement of glucose-regulated protein 78 and spliced x-box binding protein 1 in the protective effect of gliclazide in diabetic nephropathy[J]. Diabetes Res Clin Pr, 2018, 146(2): 41-47.
[7] Abd El Motteleb DM, Abd El Aleem DI. Renoprotective effect of Hypericum perforatum against diabetic nephropathy in rats: Insights in the underlying mechanisms[J]. Clin Exp Pharmacol Physiol, 2017, 44(4): 509-521.
[8] 程杰坤, 孙小慧, 高莉萍, 等. 法舒地尔对异丙肾上腺素诱导大鼠心肌肥厚的干预作用及其机制[J]. 中国应用生理学杂志, 2016, 32(5): 414-418.
[9] 张恒, 陶敏, 康品方, 等. 厄贝沙坦对糖尿病大鼠心肌损伤中Notch1信号通路的影响[J]. 中国应用生理学杂志, 2018, 34(5): 427-431.
[10]Rubler S, Dlugash J, Yuceoglu YZ, et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis[J]. Am J Cardiol, 1972, 30(6): 595-602.
[11]Kaikita K, Ogawa H. Rho-kinase pathway[J]. Circ J, 2012, 76(11): 2536-2537.
[12]Etienne-Manneville S, Hall A . Rho GTPase in cell biology[J]. Nature, 2003, 420(6916): 629-635.
[13]李健, 陈天萌, 曹剑, 等. 上调血红素氧合酶1对糖尿病心肌梗死大鼠心功能的远期影响[J]. 中国应用生理学杂志, 2014, 30(5): 421-426.
[14]Takahashi T, Harris RC. Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabeticeNOS knockout mice[J]. J Diabetes Res, 2014, 20(14): 541-590
[15]Di Lorenzo A, Lin MI, Murata T, et al. eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases[J]. J Cell Sci, 2013, 126(24): 5541-5552.
[16]Soliman H, Craig GP, Nagareddy P, et al. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats[J]. Crdiovasc Res, 2008, 79(2): 322-330.
[17]Zhou H, Sun Y, Zhang L, et al. The RhoA/ROCK pathway mediates high glucose-induced cardiomyocyte apoptosis via oxidative stress, JNK, and p38MAPK pathways[J]. Diabetes Metab Res Rev, 2018, 34(6): 3022-3029.
[18]Xie X, Peng J, Chang X, et al. Activation of RhoA/ROCK regulates NF-κB signaling pathway in experimental diabetic nephropathy[J]. Mol Cell Endocrinol, 2013, 369(1-2): 86-97.
[19]Eid S, Sas KM, Abcouwer SF, et al. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism[J]. Diabetologia, 2019, 62(9): 1539-1549.

格列齐特对糖尿病大鼠心肌的保护作用及其机制^*

Protective effects of gliclazide on myocardium of diabetic rats and its mechanism

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	冯子奕, 李雪蕊, 陈龙, 周颖, 常越辰, 马克涛, 司军强, 李丽. T16Ainh-A01对耳蜗血管纹毛细血管内皮细胞凋亡及衰老的影响^*[J]. 中国应用生理学杂志, 2020, 36(5): 385-389.
[2]	董嵩, 刘培敏, 杜向阳, 李凤岩, 曹营, 林大勇, 白剑. 甘草次酸抑制骨肉瘤细胞MG63增殖的NF-κB信号通路机制^*[J]. 中国应用生理学杂志, 2020, 36(5): 399-401.
[3]	高丽, 张文慧, 王羽维, 朱晓佳, 肖钰洁, 高倩雯, 李伟, 陈龙. 苍术素对大鼠心脏正性肌力的作用及其机制^*[J]. 中国应用生理学杂志, 2020, 36(5): 408-413.
[4]	李杰茹, 任静, 杨胜昌, 韩聚强, 郭亚净, 吉恩生. 消痰化瘀利窍中药组方对改善慢性间歇性低氧大鼠心肌纤维化的作用及其机制^*[J]. 中国应用生理学杂志, 2020, 36(5): 414-418.
[5]	贾祥磊, 刘玉珍, 李超红, 范娅楠. 多巴胺对急性间歇性低氧诱导的大鼠颈动脉体低氧敏感性的影响^*[J]. 中国应用生理学杂志, 2020, 36(5): 428-431.
[6]	谢亚磊, 梅颂, 熊艳蕾, 刘诗颖, 徐成丽. 模拟海拔5 500 m低压低氧环境对大鼠HPT轴和肠道菌群的影响^*[J]. 中国应用生理学杂志, 2020, 36(5): 432-437.
[7]	郭锐, 秦卫帅, 张双勇, 张淑玲. 甘麦大枣汤对抑郁模型大鼠海马神经元突触结构及结构蛋白表达的影响^*[J]. 中国应用生理学杂志, 2020, 36(5): 444-448.
[8]	孙林, 柏友萍, 林伟其. 脂肪因子Vaspin在运动与甲鱼油对老年肥胖大鼠胰岛素抵抗的作用^*[J]. 中国应用生理学杂志, 2020, 36(5): 461-464.
[9]	刘玉倩, 张静, 高丽娜, 王海涛. 有氧运动对高糖高脂膳食大鼠腓肠肌Nrf2-SOD的影响^*[J]. 中国应用生理学杂志, 2020, 36(5): 481-485.
[10]	赵家荣, 冯雪松, 李宏, 王国全, 张艳芳, 史海龙, 李媛媛, 晁旭. 四逆散对人肝癌HepG2细胞增殖、凋亡的影响及其机制^*[J]. 中国应用生理学杂志, 2020, 36(5): 489-493.
[11]	胡泉东, 杨玉娟, 余珊珊. 脂氧素受体激动剂BML-111对大鼠急性肝损伤的干预作用及其机制^*[J]. 中国应用生理学杂志, 2020, 36(5): 494-498.
[12]	程小丽, 赵余珠, 王志旺, 丁茂鹏, 韦凌霞, 潘虹. 七味育肝颗粒对肝纤维化大鼠的防治作用^*[J]. 中国应用生理学杂志, 2020, 36(5): 499-502.
[13]	黄磊, 潘群皖, 胡慧娴, 徐晓燕. 基于前额联络皮层脑电信号的海洛因戒断大鼠个体觅药行为状态识别^*[J]. 中国应用生理学杂志, 2020, 36(5): 517-523.
[14]	崔笑梅, 曹建民, 张静, 周海涛, 牛衍龙, 胡戈, 郭娴, 李兆岩. 有氧运动联合黑果枸杞对高脂膳食大鼠心肌脂代谢某些指标的影响^*[J]. 中国应用生理学杂志, 2020, 36(4): 301-305.
[15]	朱梅菊, 毛泽华, 郭红英, 朱洪竹, 丁孝民. 石菖蒲及α-细辛醚对疲劳运动大鼠学习记忆的影响及其机制^*[J]. 中国应用生理学杂志, 2020, 36(4): 306-311.